Recent 8-K filings for COYA

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 12:48 UTC other_material item 1.01item 9.01

  Coya Therapeutics enters $30M at-the-market equity offering with Leerink Partners

• May 12, 2026 11:39 UTC earnings item 2.02item 8.01item 9.01

  Coya Therapeutics Q1 net loss $7.2M; cash $50.7M; FDA Fast Track for COYA 302 in ALS

source · COYA on sec.gov